Implementation of a single-port robotic platform into your colorectal surgery practice: a SAGES colorectal committee task force review of evolving robotic technology and innovations - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Integrating Single-Port Robotic Technology into Colorectal Surgery: A SAGES Committee Review of Emerging Platforms and Innovations

  • By

  • Ankit Sarin

  • Justin Dourado

  • Christopher M. Seffren

  • Upinder S. Sidhu

  • Poya Pourghaderi

  • Nathan Aminpour

  • Elisabeth C. McLemore

  • Giovanni Dapri

  • Nawar A. Alkhamesi

  • Sherief Shawki

  • Brooklyn Williams

  • Muhammed Elhadi

  • Scott Nguyen

  • Alison Wenholz

  • Patricia Sylla

  • Laila Rashidi

  • October 12, 2026

Share

  • 1

    The FDA-approved single-port robotic platform received specific approval for colorectal surgery in 2024 and uses a 25-mm multichannel cannula.

  • 2

    Three articulating instruments and a flexible 3-dimensional camera preserve triangulation through one incision, addressing limitations of single-incision laparoscopy.

  • 3

    The platform’s 360-degree boom rotation enables access to multiple abdominal quadrants without repositioning, which can aid complex colorectal operations.

  • 4

    Evidence that single-port approaches reduce wound morbidity remains limited, and equivalence to multiport robotic surgery has not been established.

  • 5

    The committee reviewed platform features, workflow, technical methods, patient selection, and implementation across TAMIS, right colectomy, and LAR/TME.

Original Source(s)

Implementation of a single-port robotic platform into your colorectal surgery practice: a SAGES colorectal committee task force review of evolving robotic technology and innovations

  • by Ankit Sarin, Justin Dourado, Christopher M. Seffren, Upinder S. Sidhu, Poya Pourghaderi, Nathan Aminpour, Elisabeth C. McLemore, Giovanni Dapri, Nawar A. Alkhamesi, Sherief Shawki, Brooklyn Williams, Muhammed Elhadi, Scott Nguyen, Alison Wenholz, Patricia Sylla, Laila Rashidi

  • October 12, 2026

Related Content

Perioperative splanchnic perfusion variation around colorectal surgery using both indocyanine green spectrophotometry and fluorescence angiography

Predictors of increased acute postoperative pain after elective minimally invasive colorectal surgery

Neoadjuvant Chemo Did Not Improve Disease-Free Survival

Phase 3 NeoCol trial adds to mixed evidence as field shifts toward biomarker-guided approaches